Wafik S. El-Deiry: 3rd China – US Anti-Cancer Summit bringing together leaders

Wafik S. El-Deiry posted on X/Twitter:

“Great presentations by leaders in the field and discussions at the 3rd China – US Anti-Cancer Summit bringing together leaders from the American Association for Cancer Research, the American Society of Clinical Oncology, American Cancer Society, China Anti-Cancer Association (CACA) and Chinese Society of Clinical Oncology.

There is much progress and many opportunities for collaboration to increase access, equity and to accelerate impact. The burden of cancer varies, underlying causes and mortality outcomes also vary in US vs China.

Hoping for more support of international collaboration against the common enemy known as cancer. More funding, more harmonization of methodologies, data standardization and information sharing would help.”

Source: Wafik S. El-Deiry/X

Wafik El-Deiry, MD, PhD, FACP, FRSM, an American Cancer Society Research Professor, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. This has been the most highly cited original work published in Cell.

He discovered TRAIL receptor DR5 as a p53 target, and ONC201/TIC10 as a TRAIL pathway, integrated stress response inducer, and cancer therapeutic with efficacy in diffuse midline glioma and other tumors.  He was named one of America’s Top Oncologists by the Consumer Res Council of America in 2008 and 2009. He is a practicing physician-scientist specializing in colorectal cancer treatment.